Andy Hsieh
Stock Analyst at William Blair
(0.58)
# 3,006
Out of 4,413 analysts
6
Total ratings
33.33%
Success rate
-9.41%
Average return
Main Sectors:
Top Industries:
4 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FUSN Fusion Pharmaceuticals | Downgrades: Market Perform | n/a | $21.42 | - | 2 | Mar 19, 2024 | |
| LNTH Lantheus Holdings | Initiates: Outperform | n/a | $67.39 | - | 1 | Sep 29, 2023 | |
| FGEN FibroGen | Downgrades: Market Perform | n/a | $1.17 | - | 2 | Jun 26, 2023 | |
| ATNM Actinium Pharmaceuticals | Downgrades: Market Perform | n/a | $7.78 | - | 1 | Feb 21, 2023 |
Fusion Pharmaceuticals
Mar 19, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $21.42
Upside: -
Lantheus Holdings
Sep 29, 2023
Initiates: Outperform
Price Target: n/a
Current: $67.39
Upside: -
FibroGen
Jun 26, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $1.17
Upside: -
Actinium Pharmaceuticals
Feb 21, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $7.78
Upside: -